LianBio
LIANY · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $482 | $160 | $244 | $210 |
| - Cash | $439 | $103 | $104 | $102 |
| + Debt | $2 | $3 | $3 | $4 |
| Enterprise Value | $46 | $59 | $144 | $112 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | $383 | -$23 | -$25 | -$23 |
| % Margin | – | – | – | – |
| Net Income | $384 | -$24 | -$22 | -$24 |
| % Margin | – | – | – | – |
| EPS Diluted | 3.55 | -0.22 | -0.2 | -0.22 |
| % Growth | 1,713.6% | -10% | 9.1% | – |
| Operating Cash Flow | $312 | -$16 | -$19 | -$18 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $311 | -$16 | -$19 | -$18 |